Okta Valuation

Is 0KB7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0KB7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0KB7 ($76.55) is trading below our estimate of fair value ($138.99)

Significantly Below Fair Value: 0KB7 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0KB7?

Key metric: As 0KB7 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0KB7. This is calculated by dividing 0KB7's market cap by their current revenue.
What is 0KB7's PS Ratio?
PS Ratio5.2x
SalesUS$2.45b
Market CapUS$12.52b

Price to Sales Ratio vs Peers

How does 0KB7's PS Ratio compare to its peers?

The above table shows the PS ratio for 0KB7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.4x
RCN Redcentric
1.1x5.3%UK£185.5m
BKS Beeks Financial Cloud Group
6.1x22.1%UK£174.9m
SGE Sage Group
5.4x7.9%UK£12.6b
IOM iomart Group
0.9x9.5%UK£111.9m
0KB7 Okta
5.2x10.5%US$12.5b

Price-To-Sales vs Peers: 0KB7 is expensive based on its Price-To-Sales Ratio (5.2x) compared to the peer average (3.4x).


Price to Sales Ratio vs Industry

How does 0KB7's PS Ratio compare vs other companies in the GB IT Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
NVIQ Noventiq Holdings
0.1xn/aUS$228.10m
CLCO CloudCoCo Group
0.06xn/aUS$2.00m
No more companies available in this PS range
0KB7 5.2xIndustry Avg. 0.9xNo. of Companies6PS01.22.43.64.86+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0KB7 is expensive based on its Price-To-Sales Ratio (5.2x) compared to the European IT industry average (0.9x).


Price to Sales Ratio vs Fair Ratio

What is 0KB7's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0KB7 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.2x
Fair PS Ratio10.1x

Price-To-Sales vs Fair Ratio: 0KB7 is good value based on its Price-To-Sales Ratio (5.2x) compared to the estimated Fair Price-To-Sales Ratio (10.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0KB7 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$76.55
US$97.01
+26.7%
15.8%US$140.00US$75.00n/a36
Nov ’25US$73.09
US$98.55
+34.8%
15.6%US$140.00US$75.00n/a35
Oct ’25US$72.67
US$106.45
+46.5%
14.2%US$140.00US$75.00n/a36
Sep ’25US$78.92
US$108.64
+37.7%
13.0%US$140.00US$75.00n/a36
Aug ’25US$91.02
US$114.95
+26.3%
10.0%US$140.00US$95.00n/a36
Jul ’25US$93.82
US$114.89
+22.5%
10.1%US$140.00US$95.00n/a36
Jun ’25US$86.44
US$114.25
+32.2%
11.2%US$140.00US$81.14n/a37
May ’25US$93.02
US$113.42
+21.9%
11.8%US$140.00US$81.14n/a38
Apr ’25US$104.75
US$113.42
+8.3%
11.8%US$140.00US$81.14n/a38
Mar ’25US$107.91
US$109.50
+1.5%
14.6%US$140.00US$75.00n/a38
Feb ’25US$84.99
US$87.26
+2.7%
13.4%US$120.00US$64.00n/a39
Jan ’25US$90.73
US$84.29
-7.1%
14.6%US$120.00US$64.00n/a38
Dec ’24US$71.30
US$84.04
+17.9%
14.8%US$120.00US$64.00n/a38
Nov ’24US$68.30
US$91.45
+33.9%
12.3%US$120.00US$64.00US$73.0939
Oct ’24US$81.18
US$93.94
+15.7%
11.8%US$120.00US$64.00US$72.6741
Sep ’24US$85.93
US$93.32
+8.6%
11.7%US$120.00US$64.00US$78.9241
Aug ’24US$76.11
US$92.05
+20.9%
13.1%US$120.00US$64.00US$91.0241
Jul ’24US$69.99
US$91.93
+31.3%
13.2%US$120.00US$64.00US$93.8241
Jun ’24US$75.11
US$91.76
+22.2%
13.6%US$120.00US$64.00US$86.4441
May ’24US$68.35
US$92.18
+34.9%
13.4%US$120.00US$64.00US$93.0240
Apr ’24US$86.04
US$92.08
+7.0%
13.4%US$120.00US$64.00US$104.7538
Mar ’24US$71.14
US$81.56
+14.7%
18.4%US$125.00US$45.00US$107.9137
Feb ’24US$72.79
US$80.34
+10.4%
19.0%US$125.00US$45.00US$84.9935
Jan ’24US$67.57
US$79.12
+17.1%
23.0%US$130.00US$45.00US$90.7332
Dec ’23US$66.53
US$80.68
+21.3%
25.3%US$130.00US$45.00US$71.3030
Nov ’23US$55.76
US$93.26
+67.3%
23.4%US$145.00US$45.00US$68.3029

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies